BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21569259)

  • 1. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
    Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
    BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
    Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
    J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.
    Rabinovici GD; Miller BL
    CNS Drugs; 2010 May; 24(5):375-98. PubMed ID: 20369906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
    Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
    Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
    Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; Rodríguez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
    Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odor identification in frontotemporal lobar degeneration subtypes.
    Magerova H; Vyhnalek M; Laczo J; Andel R; Rektorova I; Kadlecova A; Bojar M; Hort J
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):762-8. PubMed ID: 24939002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
    Murley AG; Rouse MA; Jones PS; Ye R; Hezemans FH; O'Callaghan C; Frangou P; Kourtzi Z; Rua C; Carpenter TA; Rodgers CT; Rowe JB
    Brain; 2020 Dec; 143(11):3449-3462. PubMed ID: 33141154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum.
    Carbayo Á; Borrego-Écija S; Turon-Sans J; Cortés-Vicente E; Molina-Porcel L; Gascón-Bayarri J; Rubio MÁ; Povedano M; Gámez J; Sotoca J; Juntas-Morales R; Almendrote M; Marquié M; Sánchez-Valle R; Illán-Gala I; Dols-Icardo O; Rubio-Guerra S; Bernal S; Caballero-Ávila M; Vesperinas A; Gelpi E; Rojas-García R
    Brain; 2024 Jan; ():. PubMed ID: 38227807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
    Aiba I; Hayashi Y; Shimohata T; Yoshida M; Saito Y; Wakabayashi K; Komori T; Hasegawa M; Ikeuchi T; Tokumaru AM; Sakurai K; Murayama S; Hasegawa K; Uchihara T; Toyoshima Y; Saito Y; Yabe I; Tanikawa S; Sugaya K; Hayashi K; Sano T; Takao M; Sakai M; Fujimura H; Takigawa H; Adachi T; Hanajima R; Yokota O; Miki T; Iwasaki Y; Kobayashi M; Arai N; Ohkubo T; Yokota T; Mori K; Ito M; Ishida C; Tanaka M; Idezuka J; Kanazawa M; Aoki K; Aoki M; Hasegawa T; Watanabe H; Hashizume A; Niwa H; Yasui K; Ito K; Washimi Y; Mukai E; Kubota A; Toda T; Nakashima K;
    Brain Commun; 2023; 5(6):fcad296. PubMed ID: 38090279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in frontotemporal lobar degeneration syndromes.
    El-Wahsh S; Finger EC; Piguet O; Mok V; Rohrer JD; Kiernan MC; Ahmed RM
    J Neurol Neurosurg Psychiatry; 2021 Jan; ():. PubMed ID: 33441385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently.
    Tomenaga T; Minatani S; Namba H; Takeda A; Yoshizaki T; Kawabe J; Keyoumu N; Morino H; Higuchi M; Matsubara T; Hatsuta H; Hasegawa M; Murayama S; Itoh Y
    Neuropathology; 2024 May; ():. PubMed ID: 38715398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter deficits from frontotemporal lobar degeneration.
    Murley AG; Rowe JB
    Brain; 2018 May; 141(5):1263-1285. PubMed ID: 29373632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration.
    Libri I; Altomare D; Bracca V; Rivolta J; Cantoni V; Mattioli I; Alberici A; Borroni B
    Am J Geriatr Psychiatry; 2024 Mar; ():. PubMed ID: 38521735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective neuropathological diagnosis of TDP-43 proteinopathies: Factors affecting immunoreactivity of phosphorylated TDP-43 in fixed post-mortem brain tissue.
    Robinson AC; Davidson YS; Minshull J; Lally I; Walker L; Mann DMA; Roncaroli F
    Neuropathology; 2024 Apr; 44(2):173-179. PubMed ID: 37528690
    [No Abstract]   [Full Text] [Related]  

  • 18. Sporadic fatal insomnia: a rapidly progressive phenotype resembling progressive supranuclear palsy.
    Romero-Fábrega JC; Lorenzo-López R; Rivas-Infante E; Escamilla-Sevilla F; Rashki M; Mínguez-Castellanos A; Carvajal-Hernández A
    Neurologia (Engl Ed); 2024 Feb; ():. PubMed ID: 38387778
    [No Abstract]   [Full Text] [Related]  

  • 19. Author Correction: Female sex mitigates motor and behavioural phenotypes in TDP-43
    Watkins J; Ghosh A; Keerie AFA; Alix JJP; Mead RJ; Sreedharan J
    Sci Rep; 2021 May; 11(1):11058. PubMed ID: 34017015
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of familial frontotemporal dementia caused by a progranulin gene mutation.
    Currens L; Harrison N; Schmidt M; Amjad H; Mu W; Scholz SW; Bang J; Pantelyat A
    Clin Park Relat Disord; 2023; 9():100213. PubMed ID: 37583427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.